*Guest article recommendation from Cellvanta Ltd. If you would like to submit an article or blog post please email [email protected].
LONDON, UK; MADRID, Spain; and SHORT HILLS, NJ – September 16, 2026 – Coulter Partners, the global advisor building leadership teams for Health, Science and Technology innovation businesses, today announces the appointment of Carlos Gómez-Arnau, Doug Roberts, and Stuart Penney as Client Partners. These strategic hires further strengthen the firm's international presence and reinforce its commitment to supporting clients across key healthcare, life sciences, and biotechnology markets.
In their twentieth year, Cambridge Network is delighted to welcome Cambridge Enterprise as a speaker for October. Cambridge Enterprise is the innovation arm of the University of Cambridge, helping University research and expertise to deliver life-changing outcomes with world-changing impact.
About Mursla Bio
Mursla Bio is UK- and Boston-based precision medicine and diagnostics company spun out of the University of Cambridge. The company has developed a clinically validated, AI-enabled platform that analyzes tissue-specific extracellular vesicles (TS-EVs) from blood to deliver tissue-resolved, multiomic insights not accessible through standard liquid biopsy approaches.
Peptide drug discovery is the process of designing, synthesising, testing and optimising peptide molecules to investigate biological targets or develop therapeutic candidates. Depending on the programme, peptides can be used for target validation, screening, structure-activity relationship (SAR) studies, optimisation and therapeutic development.
Hear from inspirational women in the sector!
Are you an experienced Project Manager who enjoys bringing together clients and technical experts to deliver high-quality outputs on complex product development programmes?
About the role:
In this role, you’ll lead the planning, control and delivery of complex product design and development projects, taking them from early concept through to transition to manufacture.
Role Overview
A senior scientific leadership role for an exceptional researcher-manager who can drive a focused, high-impact R&D programme — executing the scientific vision set by the CSO and translating it into measurable progress across Meatly's core technology pillars.
At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No.
Join us for Biscuits & Brew!
BioPartner UK's Biscuits & Brew is our online networking series, where you will have the opportunity to take a well-earned break from your busy schedule to catch up and meet with fellow attendees over a few biscuits and a nice brew. Each session will have a different theme, so make sure you don't miss out on the Biscuit and Brew: Biospain edition!
Taking place on the 16th September 2026 at 11am BST, our informal tea break gives an opportunity for you to meet BioPartner members and Biospain delegates.